Literature DB >> 33085059

The function and regulation of TET2 in innate immunity and inflammation.

Boyi Cong1, Qian Zhang2, Xuetao Cao3,4,5.   

Abstract

TET2, a member of ten-eleven translocation (TET) family as α-ketoglutarate- and Fe2+-dependent dioxygenase catalyzing the iterative oxidation of 5-methylcytosine (5mC), has been widely recognized to be an important regulator for normal hematopoiesis especially myelopoiesis. Mutation and dysregulation of TET2 contribute to the development of multiple hematological malignancies. Recent studies reveal that TET2 also plays an important role in innate immune homeostasis by promoting DNA demethylation or independent of its enzymatic activity. Here, we focus on the functions of TET2 in the initiation and resolution of inflammation through epigenetic regulation and signaling network. In addition, we highlight regulation of TET2 at various molecular levels as well as the correlated inflammatory diseases, which will provide the insight to intervene in the pathological process caused by TET2 dysregulation.

Entities:  

Keywords:  DNA demethylation; TET2; inflammatory diseases; inflammatory resolution; innate immune response

Mesh:

Substances:

Year:  2020        PMID: 33085059      PMCID: PMC7895883          DOI: 10.1007/s13238-020-00796-6

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  72 in total

1.  Vpr Targets TET2 for Degradation by CRL4VprBP E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication.

Authors:  Lei Lv; Qi Wang; Yanping Xu; Li-Chung Tsao; Tadashi Nakagawa; Haitao Guo; Lishan Su; Yue Xiong
Journal:  Mol Cell       Date:  2018-06-07       Impact factor: 17.970

2.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.

Authors:  José J Fuster; Susan MacLauchlan; María A Zuriaga; Maya N Polackal; Allison C Ostriker; Raja Chakraborty; Chia-Ling Wu; Soichi Sano; Sujatha Muralidharan; Cristina Rius; Jacqueline Vuong; Sophia Jacob; Varsha Muralidhar; Avril A B Robertson; Matthew A Cooper; Vicente Andrés; Karen K Hirschi; Kathleen A Martin; Kenneth Walsh
Journal:  Science       Date:  2017-01-19       Impact factor: 47.728

3.  TET-catalyzed 5-methylcytosine hydroxylation is dynamically regulated by metabolites.

Authors:  Hui Yang; Huaipeng Lin; Haiyan Xu; Lei Zhang; Lu Cheng; Bo Wen; Jianyong Shou; Kunliang Guan; Yue Xiong; Dan Ye
Journal:  Cell Res       Date:  2014-06-27       Impact factor: 25.617

4.  Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation.

Authors:  Qicong Shen; Qian Zhang; Yang Shi; Qingzhu Shi; Yanyan Jiang; Yan Gu; Zhiqing Li; Xia Li; Kai Zhao; Chunmei Wang; Nan Li; Xuetao Cao
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

5.  Dual mechanisms of posttranscriptional regulation of Tet2 by Let-7 microRNA in macrophages.

Authors:  Shuai Jiang; Wei Yan; Shizhen Emily Wang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-03       Impact factor: 11.205

6.  Epigenetic modulation of β cells by interferon-α via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.

Authors:  Mihaela Stefan-Lifshitz; Esra Karakose; Lingguang Cui; Abora Ettela; Zhengzi Yi; Weijia Zhang; Yaron Tomer
Journal:  JCI Insight       Date:  2019-03-07

7.  WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation.

Authors:  Yiping Wang; Mengtao Xiao; Xiufei Chen; Leilei Chen; Yanping Xu; Lei Lv; Pu Wang; Hui Yang; Shenghong Ma; Huaipeng Lin; Bo Jiao; Ruibao Ren; Dan Ye; Kun-Liang Guan; Yue Xiong
Journal:  Mol Cell       Date:  2015-01-15       Impact factor: 17.970

8.  AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma.

Authors:  J Jiao; Y Jin; M Zheng; H Zhang; M Yuan; Z Lv; W Odhiambo; X Yu; P Zhang; C Li; Y Ma; Y Ji
Journal:  Clin Exp Immunol       Date:  2018-11-13       Impact factor: 4.330

9.  Phosphorylation of TET proteins is regulated via O-GlcNAcylation by the O-linked N-acetylglucosamine transferase (OGT).

Authors:  Christina Bauer; Klaus Göbel; Nagarjuna Nagaraj; Christian Colantuoni; Mengxi Wang; Udo Müller; Elisabeth Kremmer; Andrea Rottach; Heinrich Leonhardt
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

10.  SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.

Authors:  Lei-Lei Chen; Huai-Peng Lin; Wen-Jie Zhou; Chen-Xi He; Zhi-Yong Zhang; Zhou-Li Cheng; Jun-Bin Song; Peng Liu; Xin-Yu Chen; Yu-Kun Xia; Xiu-Fei Chen; Ren-Qiang Sun; Jing-Ye Zhang; Yi-Ping Sun; Lei Song; Bing-Jie Liu; Rui-Kai Du; Chen Ding; Fei Lan; Sheng-Lin Huang; Feng Zhou; Suling Liu; Yue Xiong; Dan Ye; Kun-Liang Guan
Journal:  Cell Rep       Date:  2018-11-06       Impact factor: 9.423

View more
  16 in total

1.  TET2 regulates immune tolerance in chronically activated mast cells.

Authors:  Riccardo Rigo; Rabie Chelbi; Julie Agopian; Sebastien Letard; Aurélien Griffon; Hussein Ghamlouch; Julien Vernerey; Vasileios Ladopoulos; Edwige Voisset; Paulo De Sepulveda; Geoffrey Guittard; Jacques A Nunès; Ghislain Bidaut; Berthold Göttgens; Michael Weber; Olivier A Bernard; Patrice Dubreuil; Erinn Soucie
Journal:  JCI Insight       Date:  2022-04-08

2.  A novel epigenetic marker, Ten-eleven translocation family member 2 (TET2), is identified in the intractable epileptic brain and regulates ATP binding cassette subfamily B member 1 (ABCB1) in the blood-brain barrier.

Authors:  Fan-Cheng Kong; Li-Qin Lang; Jie Hu; Xia-Ling Zhang; Ming-Kang Zhong; Chun-Lai Ma
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 3.  Recent advancements in pulmonary arterial hypertension and right heart failure research: overview of selected abstracts from ATS2020 and emerging COVID-19 research.

Authors:  Francois Potus; Andrea L Frump; Soban Umar; Rebecca R Vanderpool; Imad Al Ghouleh; Yen-Chun Lai
Journal:  Pulm Circ       Date:  2021-08-19       Impact factor: 3.017

4.  TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes.

Authors:  Carmelo Gurnari; Simona Pagliuca; Yihong Guan; Vera Adema; Courtney E Hershberger; Ying Ni; Hassan Awada; Sunisa Kongkiatkamon; Misam Zawit; Diego F Coutinho; Ilana R Zalcberg; Jae-Sook Ahn; Hyeoung-Joon Kim; Dennis Dong Hwan Kim; Mark D Minden; Joop H Jansen; Manja Meggendorfer; Claudia Haferlach; Babal K Jha; Torsten Haferlach; Jaroslaw P Maciejewski; Valeria Visconte
Journal:  Blood Adv       Date:  2022-01-11

5.  Role of Myeloid Tet Methylcytosine Dioxygenase 2 in Pulmonary and Peritoneal Inflammation Induced by Lipopolysaccharide and Peritonitis Induced by Escherichia coli.

Authors:  Wanhai Qin; Xanthe Brands; Hisatake Matsumoto; Joe M Butler; Cornelis Van't Veer; Alex F de Vos; Joris J T H Roelofs; Brendon P Scicluna; Tom van der Poll
Journal:  Cells       Date:  2021-12-28       Impact factor: 6.600

Review 6.  Contribution of Dysregulated DNA Methylation to Autoimmunity.

Authors:  Samanta C Funes; Ayleen Fernández-Fierro; Diego Rebolledo-Zelada; Juan P Mackern-Oberti; Alexis M Kalergis
Journal:  Int J Mol Sci       Date:  2021-11-02       Impact factor: 5.923

7.  TET2 Inhibits PD-L1 Gene Expression in Breast Cancer Cells through Histone Deacetylation.

Authors:  Yinghui Shen; Lu Liu; Mengyuan Wang; Bo Xu; Ruitu Lyu; Yujiang Geno Shi; Li Tan
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

8.  Isolated ten-eleven translocation 2 positive in triple negative essential thrombocythemia: Case report and literature review.

Authors:  Rehab Y Al-Ansari; Dena Al Otaibi; Nourah Al Hudaithi; Leena Abdalla
Journal:  SAGE Open Med Case Rep       Date:  2021-07-15

9.  Genome-wide association study identifies five risk loci for pernicious anemia.

Authors:  Triin Laisk; Maarja Lepamets; Mariann Koel; Erik Abner; Reedik Mägi
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

Review 10.  Role of Tet2 in Regulating Adaptive and Innate Immunity.

Authors:  Jiaqi Li; Lifang Li; Xiaoxiao Sun; Tuo Deng; Gan Huang; Xia Li; Zhiguo Xie; Zhiguang Zhou
Journal:  Front Cell Dev Biol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.